Market Estimates
Valuation Metrics
Financials
Trading Trends
ARWR News & Events
Events Timeline

No data
News
People Also Watch
Frequently Asked Questions
What is Arrowhead Pharmaceuticals Inc (ARWR) stock price today?
The current price of ARWR is 65 USD — it has decreased -1.05 % in the last trading day.
What is Arrowhead Pharmaceuticals Inc (ARWR)'s business?
Arrowhead Pharmaceuticals, Inc. develops medicines that treat intractable diseases by silencing the genes that cause them. The Company's therapies, using a broad portfolio of ribonucleic acid (RNA) chemistries and modes of delivery, trigger the RNA interference (RNAi) mechanism to induce rapid, deep and durable knockdown of target genes. The Company's Targeted RNAi Molecule (TRiMTM) platform utilizes ligand-mediated delivery and is designed to enable tissue-specific targeting while being structurally simple. It is focused on various therapeutic areas, such as cardiometabolic, pulmonary, liver, muscle and central nervous system. It has around 16 clinical-stage investigational medicines (wholly owned and partnered), which range in development stage from Phase I to Phase III. The Company's pipeline products include Plozasiran, Zodasiran, Olpasiran, ARO-RAGE, ARO-MMP7, GSK-4532990, Fazirsiran, GSK5637608, ARO-CFB, ARO-INHBE, ARO-C3, ARO-PNPLA3, ARO-DUX4, ARO-DM1 and ARO-ATXN2.
What is the price predicton of ARWR Stock?
Wall Street analysts forecast ARWR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ARWR is 61.63 USD with a low forecast of 48.00 USD and a high forecast of 85.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
What is Arrowhead Pharmaceuticals Inc (ARWR)'s revenue for the last quarter?
Arrowhead Pharmaceuticals Inc revenue for the last quarter amounts to 256.47M USD, decreased % YoY.
What is Arrowhead Pharmaceuticals Inc (ARWR)'s earnings per share (EPS) for the last quarter?
Arrowhead Pharmaceuticals Inc. EPS for the last quarter amounts to -0.17 USD, decreased -87.59 % YoY.
What changes have occurred in the market's expectations for Arrowhead Pharmaceuticals Inc (ARWR)'s fundamentals?
How many employees does Arrowhead Pharmaceuticals Inc (ARWR). have?
Arrowhead Pharmaceuticals Inc (ARWR) has 711 emplpoyees as of January 09 2026.
What is Arrowhead Pharmaceuticals Inc (ARWR) market cap?
Today ARWR has the market capitalization of 8.83B USD.


![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F90583abbe59e720c75034873839b10c39d1b48b42a37a7af93d5d7141d4fee84.png&w=384&q=75)